BHC:CA Bausch Health Companies Inc

CAD 10.42 -0.04 -0.382409
Icon

Bausch Health Companies Inc (BHC:CA) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | TSX
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 10.42

-0.04 (-0.38)%

CAD 3.84B

0.17M

CAD 11.60(+11.32%)

CAD 15.43 (+48.08%)

Icon

BHC:CA

Bausch Health Companies Inc (CAD)
COMMON STOCK | TSX
CAD 10.42
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

CAD 3.84B

CAD 15.43 (+48.08%)

CAD 10.42

Bausch Health Companies Inc (BHC:CA) Stock Forecast

CAD 11.60
(+11.32%)

Based on the Bausch Health Companies Inc stock forecast from 3 analysts, the average analyst target price for Bausch Health Companies Inc is CAD 11.60 over the next 12 months. Bausch Health Companies Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Bausch Health Companies Inc is Neutral, which is based on 7 positive signals and 6 negative signals. At the last closing, Bausch Health Companies Inc’s stock price was CAD 10.42. Bausch Health Companies Inc’s stock price has changed by +3.89% over the past week, +12.16% over the past month and -17.56% over the last year.

No recent analyst target price found for Bausch Health Companies Inc
No recent average analyst rating found for Bausch Health Companies Inc

Company Overview Bausch Health Companies Inc

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, inter...Read More

2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8

20,270

December

CAD

Canada

Adjusted Closing Price for Bausch Health Companies Inc (BHC:CA)

Loading...

Unadjusted Closing Price for Bausch Health Companies Inc (BHC:CA)

Loading...

Share Trading Volume for Bausch Health Companies Inc Shares

Loading...

Compare Performance of Bausch Health Companies Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BHC:CA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bausch Health Companies Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CURA:CA
Curaleaf Holdings Inc. +0.18 (+3.16%) CAD3.89B N/A N/A

ETFs Containing BHC:CA

Symbol Name BHC:CA's Weight Expense Ratio Price(Change) Market Cap
QHY:CA
Mackenzie US High Yield B.. 0.98 % 0.00 % 0.00 (0.00%) CAD0.04B

Frequently Asked Questions About Bausch Health Companies Inc (BHC:CA) Stock

Based on ratings from 3 analysts Bausch Health Companies Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 3 hold ratings.

Unfortunately we do not have enough data on BHC:CA's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for BHC:CA is CAD 11.60 over the next 12 months. The maximum analyst target price is CAD 16 while the minimum anlayst target price is CAD 8.

BHC:CA stock's Price/Earning ratio is 11.95. Our analysis grades BHC:CA stock's Price / Earning ratio at F. This means that BHC:CA stock's Price/Earning ratio is above 53% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the TSX exchange. Based on this BHC:CA may be a overvalued for its sector.

The last closing price of BHC:CA's stock was CAD 10.42.

The most recent market capitalization for BHC:CA is CAD 3.84B.

Based on targets from 3 analysts, the average taret price for BHC:CA is projected at CAD 11.60 over the next 12 months. This means that BHC:CA's stock price may go up by +11.32% over the next 12 months.

Following are ETFs with the highest allocation to Bausch Health Companies Inc's stock :

QHY:CA

As per our most recent records Bausch Health Companies Inc has 20,270 Employees.

Bausch Health Companies Inc's registered address is 2150 St. ElzEar Boulevard West, Laval, QC, Canada, H7L 4A8. You can get more information about it from Bausch Health Companies Inc's website at https://www.bauschhealth.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...